Therefore, we analyzed possible correlations between the level of MGRN1 expression and clinical parameters in human melanoma patients, using a combination of in silico analyses of data compiled in public databases and preliminary studies in a cohort of nevi and melanoma biopsies obtained at the BBHRI. This evidence concerns the gene MGRN1 and melanoma.